Effect of SL and SLG on fasting blood glucose (A) IPGTT; (B), fasting insulin; (C) HOMA-IR; (D) hepatic glucogenic enzymes; (E) hepatic IRS2 gene; (F) plasma GIP; (G) plasma adipokines; (H) and plasma pro-inflammatory cytokines in C57BL/6J mice fed HFD for 12 weeks. Data are shown as the mean ± SEM (n = 10). Significant differences between HFD versus ND are indicated; * p < 0.001, ** p < 0.01, *** p < 0.001. ab Means not sharing a common superscript are significantly different among the high-fat diet fed groups (HFD, SL, and SLG groups) at p < 0.05. ND, normal diet group; HFD, high-fat diet group; SL, HFD + 1.8% (w/w) ethanol extract of sea buckthorn leaves group; SLG, HFD + 0.04% (w/w) ethanol extract of flavonoid glycosides from sea buckthorn leaves group; IPGTT, intraperitoneal glucose tolerance test; HOMA-IR, homeostasis model assessment-estimated insulin resistance; PEPCK, phosphoenolpyruvate carboxykinase; G6Pase, glucokinase, glucose-6-phosphatase; IRS2, insulin receptor substrate 2; GIP, incretin hormone gastric inhibitory polypeptide; L:A Ratio, leptin:adiponectin ratio; TNF-α, tumor necrosis factor α; IL, interleukin; PAI-1, plasminogen activator inhibitor-1.